Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

Benzinga Newsdesk www.benzinga.com Negative 77.9%

Neg 77.9% Neu 0% Pos 0%

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $98 to $95.